BioNTech reviews

3.2

40% would recommend to a friend

(26 total reviews)
avatar

Ugur Sahin

45% approve of CEO

34% positive business outlook

Reviews by job title

26 reviews

Reviews about "Compensation"

Return to all reviews
4.0
Feb 4, 2022

Growing Pains for US

Recommend
CEO approval
Business Outlook

Pros

* We get to work on a globally-recognized life saving product as well as develop novel therapies against cancer and a variety of infectious diseases * Fast company growth gives employees the ability to climb the ranks of the company faster than elsewhere and help to develop new workflows and procedures * Comfortable work life balance * Fair but competitive compensation

Cons

* Process are still being developed and timelines to get global projects done are long and unpredictable. It can take a year to get approval to work with a new vendor * Non-German sites seem to be treated as afterthoughts to the company as a whole. Decisions are made in Germany without any input from US stakeholders.

1.0
Sep 4, 2021

Exciting science, growing pains

Recommend
CEO approval
Business Outlook

Pros

- focus on scientific innovation - good working culture in US

Cons

- German processes crippling US location - naive mindset - bad work hours compared to biotech and pharma peers - talent gap in executive leadership - internal politics between groups getting more complicated - lower pay than peers - limited diversity

Viewing 22 - 24 of 26 Reviews

Glassdoor has 294 BioNTech reviews submitted anonymously by BioNTech employees. Read employee reviews and ratings on Glassdoor to decide if BioNTech is right for you.